A Phase 3B Open-Label Follow-on Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women
Phase of Trial: Phase III
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors International Partnership for Microbicides
- 20 Nov 2017 Planned End Date changed from 1 Sep 2017 to 1 Mar 2018.
- 20 Nov 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2018.
- 23 Aug 2016 Status changed from not yet recruiting to recruiting.